Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104315609> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2104315609 endingPage "3520" @default.
- W2104315609 startingPage "3509" @default.
- W2104315609 abstract "Cystic fibrosis (CF) is a multisystem disease associated with mutations in the gene that encodes the CF transmembrane conductance regulatory (CFTR) protein. The majority of wild-type CFTR and virtually all mutant ΔF508 CFTR are degraded before reaching the cell surface. Certain agents and conditions that increase expression and maturation of CFTR enable the protein to function at the cell surface. We and several research groups have reported that S-nitrosoglutathione (GSNO), a class of endogenous S-nitrosothiols, increases the maturation and function of CFTR in human airway epithelial cells. S-nitrosothiols (SNOs) are endogenous molecules with several cell signaling effects and potential relevance to human lung disease. SNOs are normally present in the human airway and have beneficial effects on lung function. Biochemical evidence suggests that SNOs act on post-translational protein modifications through mechanisms involving S-nitrosylation reactions. S-nitrosylation reactions are increasingly recognized to represent metabolically regulated cell signaling processes. Airway epithelial S-nitrosylation signaling disorders have been observed in a range of diseases, including CF. SNO levels are low in CF patients and normal physiological concentrations are effective in increasing CFTR maturation. The mechanisms by which SNOs improve CFTR expression appear to be novel. However, the precise mechanisms by which SNOs exert their beneficial effects are poorly understood. In the near future, we expect to identify the novel mechanisms by which SNO augments CFTR maturation. This information will be critical for optimizing the design and dosing of SNOs that might be used as CFTR corrector therapies in clinical trials. Keywords: Cystic fibrosis, CFTR, S-nitrosothiols, S-nitrosylation, molecular therapy." @default.
- W2104315609 created "2016-06-24" @default.
- W2104315609 creator A5025744049 @default.
- W2104315609 creator A5058801115 @default.
- W2104315609 creator A5087033191 @default.
- W2104315609 date "2013-04-01" @default.
- W2104315609 modified "2023-09-25" @default.
- W2104315609 title "Novel S-Nitrosothiols Have Potential Therapeutic Uses for Cystic Fibrosis" @default.
- W2104315609 doi "https://doi.org/10.2174/13816128113199990319" @default.
- W2104315609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23331028" @default.
- W2104315609 hasPublicationYear "2013" @default.
- W2104315609 type Work @default.
- W2104315609 sameAs 2104315609 @default.
- W2104315609 citedByCount "10" @default.
- W2104315609 countsByYear W21043156092013 @default.
- W2104315609 countsByYear W21043156092014 @default.
- W2104315609 countsByYear W21043156092015 @default.
- W2104315609 countsByYear W21043156092016 @default.
- W2104315609 countsByYear W21043156092017 @default.
- W2104315609 crossrefType "journal-article" @default.
- W2104315609 hasAuthorship W2104315609A5025744049 @default.
- W2104315609 hasAuthorship W2104315609A5058801115 @default.
- W2104315609 hasAuthorship W2104315609A5087033191 @default.
- W2104315609 hasConcept C1491633281 @default.
- W2104315609 hasConcept C164718446 @default.
- W2104315609 hasConcept C170493617 @default.
- W2104315609 hasConcept C181199279 @default.
- W2104315609 hasConcept C185592680 @default.
- W2104315609 hasConcept C203014093 @default.
- W2104315609 hasConcept C24530287 @default.
- W2104315609 hasConcept C2776938444 @default.
- W2104315609 hasConcept C2777553025 @default.
- W2104315609 hasConcept C2778428886 @default.
- W2104315609 hasConcept C2779201268 @default.
- W2104315609 hasConcept C54355233 @default.
- W2104315609 hasConcept C55493867 @default.
- W2104315609 hasConcept C62478195 @default.
- W2104315609 hasConcept C86803240 @default.
- W2104315609 hasConcept C95444343 @default.
- W2104315609 hasConceptScore W2104315609C1491633281 @default.
- W2104315609 hasConceptScore W2104315609C164718446 @default.
- W2104315609 hasConceptScore W2104315609C170493617 @default.
- W2104315609 hasConceptScore W2104315609C181199279 @default.
- W2104315609 hasConceptScore W2104315609C185592680 @default.
- W2104315609 hasConceptScore W2104315609C203014093 @default.
- W2104315609 hasConceptScore W2104315609C24530287 @default.
- W2104315609 hasConceptScore W2104315609C2776938444 @default.
- W2104315609 hasConceptScore W2104315609C2777553025 @default.
- W2104315609 hasConceptScore W2104315609C2778428886 @default.
- W2104315609 hasConceptScore W2104315609C2779201268 @default.
- W2104315609 hasConceptScore W2104315609C54355233 @default.
- W2104315609 hasConceptScore W2104315609C55493867 @default.
- W2104315609 hasConceptScore W2104315609C62478195 @default.
- W2104315609 hasConceptScore W2104315609C86803240 @default.
- W2104315609 hasConceptScore W2104315609C95444343 @default.
- W2104315609 hasIssue "19" @default.
- W2104315609 hasLocation W21043156091 @default.
- W2104315609 hasLocation W21043156092 @default.
- W2104315609 hasOpenAccess W2104315609 @default.
- W2104315609 hasPrimaryLocation W21043156091 @default.
- W2104315609 hasRelatedWork W2079055028 @default.
- W2104315609 hasRelatedWork W2106113444 @default.
- W2104315609 hasRelatedWork W2121996960 @default.
- W2104315609 hasRelatedWork W2137006241 @default.
- W2104315609 hasRelatedWork W2623234503 @default.
- W2104315609 hasRelatedWork W2765286032 @default.
- W2104315609 hasRelatedWork W2897997652 @default.
- W2104315609 hasRelatedWork W3026310509 @default.
- W2104315609 hasRelatedWork W3113121415 @default.
- W2104315609 hasRelatedWork W3207166609 @default.
- W2104315609 hasVolume "19" @default.
- W2104315609 isParatext "false" @default.
- W2104315609 isRetracted "false" @default.
- W2104315609 magId "2104315609" @default.
- W2104315609 workType "article" @default.